688217 睿昂基因
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.620-1.7000.8424.4346.165
总资产报酬率 ROA (%)-0.581-1.5530.7453.9855.705
投入资产回报率 ROIC (%)-0.605-1.6360.8134.3236.019

边际利润分析
销售毛利率 (%)73.45374.52873.21160.80073.108
营业利润率 (%)-11.499-11.730-2.51316.90112.529
息税前利润/营业总收入 (%)-12.741-12.923-5.07715.36114.437
净利润/营业总收入 (%)-8.849-10.692-1.86115.53613.775

收益指标分析
经营活动净收益/利润总额(%)88.48730.3761.691124.44966.951
价值变动净收益/利润总额(%)-10.068-8.750-32.0324.3338.391
营业外收支净额/利润总额(%)3.1290.18530.983-0.32314.116

偿债能力分析
流动比率 (X)15.20412.14211.9676.93116.637
速动比率 (X)13.93311.02110.5446.33315.523
资产负债率 (%)4.1676.6007.32510.3755.368
带息债务/全部投入资本 (%)0.1322.1172.2720.5330.224
股东权益/带息债务 (%)74,859.6854,560.1904,222.67418,236.10843,618.024
股东权益/负债合计 (%)2,288.1831,397.6271,236.560833.1971,747.354
利息保障倍数 (X)14.65011.0343.534-10.337-95.100

营运能力分析
应收账款周转天数 (天)311.805262.349308.851177.977202.927
存货周转天数 (天)293.193303.469298.23698.723147.966